IL10 and neoplasm: However, recent studies have discovered that skeletal muscle produces and releases a cytokine that is further involved in the anti-inflammatory response, including mediating the interaction of the pro-inflammatory cytokine interleukin-6 with NK cells to induce the production of IL-1 receptor antagonists and IL-10, thereby acting as an anti-tumour agent [35, 36].